BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7105430)

  • 1. Menstrual function and serum prolactin levels after long-term bromocriptine treatment of hyperprolactinaemic amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1982 Jun; 16(6):587-93. PubMed ID: 7105430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bromocriptine treatment of secondary amenorrhoea.
    Seppalå M; Hirvonen E; Ranta T
    Lancet; 1976 May; 1(7970):1154-6. PubMed ID: 58200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperprolactinaemia and luteal insufficiency.
    Seppälä M; Ranta T; Hirvonen E
    Lancet; 1976 Jan; 1(7953):229-30. PubMed ID: 55535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of bromocriptine in hyperprolactinaemic anovulation and related disorders.
    Franks S
    Drugs; 1979 May; 17(5):337-48. PubMed ID: 378649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin secretion and menstrual function after long-term bromocriptine treatment.
    Rasmussen C; Bergh T; Wide L
    Fertil Steril; 1987 Oct; 48(4):550-4. PubMed ID: 3653413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and significance of hyperprolactinaemia in women with amenorrhea.
    Franks S; Murray MA; Jequier AM; Steele SJ; Nabarro JD; Jacobs HS
    Clin Endocrinol (Oxf); 1975 Nov; 4(6):597-607. PubMed ID: 1104218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metergoline as an alternative to bromocriptine in amenorrhoea.
    Hicks BH; Finer N; Herbert LC
    Acta Endocrinol (Copenh); 1984 Dec; 107(4):439-44. PubMed ID: 6440388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy.
    Moult PJ; Rees LH; Besser GM
    Clin Endocrinol (Oxf); 1982 Feb; 16(2):153-62. PubMed ID: 6802531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine treatment of 42 hyperprolactinaemic women with secondary amenorrhoea.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1978 Jul; 88(3):435-51. PubMed ID: 354299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bromocriptine treatment of hyperprolactinaemic hypogonadism.
    Thorner MO; Besser GM
    Acta Endocrinol Suppl (Copenh); 1978; 216():131-46. PubMed ID: 347858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine in the treatment of secondary amenorrhoea and ovarian dysfunction in hyper- and normo-prolactinaemic patients.
    Milligan MP; Moore DM; Singh MM; Buckingham MS; Elstein M
    Curr Med Res Opin; 1978; 5(9):734-8. PubMed ID: 367717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea.
    Aono T; Miyake A; Yasuda TS; Koike K; Kurachi K
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):591-600. PubMed ID: 227202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal LH pulsatility in women with hyperprolactinaemic amenorrhoea normalizes after bromocriptine treatment: deconvolution-based assessment.
    Sartorio A; Pizzocaro A; Liberati D; De Nicolao G; Veldhuis JD; Faglia G
    Clin Endocrinol (Oxf); 2000 Jun; 52(6):703-12. PubMed ID: 10848874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and endocrine features of hyperprolactinaemic amenorrhoea.
    Jacobs HS; Franks S; Murray MA; Hull MG; Steele SJ; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):439-54. PubMed ID: 825329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bromocriptine treatment of seven women with primary amenorrhoea and prolactin-secreting pituitary tumours.
    Bergh T; Nillius SJ; Wide L
    Clin Endocrinol (Oxf); 1979 Feb; 10(2):145-54. PubMed ID: 570900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinaemia in amenorrhoea - incidence and clinical significance.
    Bergh T; Nillius SJ; Wide L
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):683-94. PubMed ID: 335758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of placebo and bromocriptine in the treatment of patients with normoprolactinaemic amenorrhoea.
    Crosignani PG; Reschini E; Lombroso GC; Arosio M; Peracchi M
    Br J Obstet Gynaecol; 1978 Oct; 85(10):773-5. PubMed ID: 361068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine and oestrogen modulation of gonadotrophin release in normo- and hyperprolactinaemic patients with amenorrhoea.
    Djursing J; Hagen C; Christensen F; Nickelsen C
    Clin Endocrinol (Oxf); 1981 Aug; 15(2):125-32. PubMed ID: 6796299
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyperprolactinaemic amenorrhoea in Hong Kong.
    Tang LC; Sung ML; Ma HK
    Aust N Z J Obstet Gynaecol; 1983 Aug; 23(3):165-9. PubMed ID: 6580885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lipoprotein profile of women with hyperprolactinaemic amenorrhoea.
    Fahy U; Hopton MI; Hartog M; Bolton CH; Hull MG
    Hum Reprod; 1999 Feb; 14(2):285-7. PubMed ID: 10099964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.